Innovation Network and Capital Act of 2019

House Bill 5357 - Innovation Network and Capital Act of 2019: Overview, Status, and Impact

Hozzl · 2022-10-28T01:46:03Z

Explore the details of House Bill 5357 Innovation Network and Capital Act of 2019 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

10/28/2022, 1:46 AM

Congressional Summary of HR 5357

Innovation Network and Capital Act of 2019

This bill establishes and provides funds through FY2025 for a grant program in the National Institutes of Health (NIH) to expand the commercialization of biomedical products. NIH shall award grants or contracts to entities that have received funding from either the Small Business Innovation Research Program or the Small Business Technology Transfer Program of NIH. Awardees must use the funds to support participation in specified NIH programs and activities related to the commercialization stage of research, later stage research and development, technology transfer, and commercialization technical assistance.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5357

Bill HR 5357 is currently in the status of Bill Introduced since December 6, 2019. Bill HR 5357 was introduced during Congress 116 and was introduced to the House on December 6, 2019. Bill HR 5357's most recent activity was Referred to the Subcommittee on Health. as of December 9, 2019

Bipartisan Support of Bill HR 5357

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5357

Primary Policy Focus

Health

Potential Impact Areas

- Health technology, devices, supplies

- Medical research

- Research administration and funding

- Technology transfer and commercialization

Alternate Title(s) of Bill HR 5357

Innovation Network and Capital Act of 2019

To amend the Public Health Service Act to authorize a pilot program to develop, expand, and enhance the commercialization of biomedical products, and for other purposes.

Innovation Network and Capital Act of 2019